Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership17,007 shares
Latest Disclosed Value $ 76,532
Citigroup Inc ownership in MYGN / Myriad Genetics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 17,007 shares of Myriad Genetics, Inc. (US:MYGN) valued at $76,532 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 35,930 shares of Myriad Genetics, Inc.. This represents a change in shares of -52.67% during the quarter. The current value of the position is $74,831 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (MYGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MYGN / Myriad Genetics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F MYRIAD GENETICS COM 62855J104 17,007 -18,923 -52.67 77 -65.45 0.0000
2026-02-13 2025-12-31 13F MYRIAD GENETICS COM 62855J104 35,930 -43,565 -54.80 221 -61.67 0.0001
2025-11-10 2025-09-30 13F MYRIAD GENETICS COM 62855J104 79,495 -44,258 -35.76 575 -12.63 0.0003
2025-08-11 2025-06-30 13F MYRIAD GENETICS COM 62855J104 123,753 -119,836 -49.20 657 -69.58 0.0003
2025-05-12 2025-03-31 13F MYRIAD GENETICS COM 62855J104 243,589 51,351 26.71 2,161 -18.03 0.0011
2025-02-12 2024-12-31 13F MYRIAD GENETICS COM 62855J104 192,238 74,056 62.66 2,636 -18.60 0.0016
2024-11-12 2024-09-30 13F MYRIAD GENETICS COM 62855J104 118,182 35,204 42.43 3,237 59.54 0.0019
2024-08-12 2024-06-30 13F MYRIAD GENETICS COM 62855J104 82,978 -184,128 -68.93 2,030 -64.37 0.0013
2024-05-10 2024-03-31 13F MYRIAD GENETICS COM 62855J104 267,106 147,679 123.66 5,695 149.19 0.0037
2024-02-09 2023-12-31 13F MYRIAD GENETICS COM 62855J104 119,427 -2,353 -1.93 2,286 17.00 0.0016
2023-12-06 2023-09-30 13F/A-1 MYRIAD GENETICS COM 62855J104 121,780 5,799 5.00 1,953 -27.34 0.0015
2023-11-09 2023-09-30 13F MYRIAD GENETICS COM 62855J104 121,780 5,799 1,953 0.0006
2023-08-10 2023-06-30 13F MYRIAD GENETICS COM 62855J104 115,981 -59,092 -33.75 2,688 -33.89 0.0018
2023-05-11 2023-03-31 13F MYRIAD GENETICS COM 62855J104 175,073 32,890 23.13 4,067 97.09 0.0029
2023-02-09 2022-12-31 13F MYRIAD GENETICS COM 62855J104 142,183 -55,320 -28.01 2,063 -45.25 0.0016
2022-11-10 2022-09-30 13F MYRIAD GENETICS COM 62855J104 197,503 48,282 32.36 3,768 38.99 0.0027
2022-08-10 2022-06-30 13F MYRIAD GENETICS COM 62855J104 149,221 42,537 39.87 2,711 0.82 0.0020
2022-05-12 2022-03-31 13F MYRIAD GENETICS COM 62855J104 106,684 -107,972 -50.30 2,689 -54.62 0.0016
2022-02-10 2021-12-31 13F MYRIAD GENETICS COM 62855J104 214,656 81,995 61.81 5,925 38.31 0.0032
2021-11-10 2021-09-30 13F MYRIAD GENETICS COM 62855J104 132,661 -70,370 -34.66 4,284 -31.00 0.0025
2021-08-10 2021-06-30 13F MYRIAD GENETICS COM 62855J104 203,031 61,974 43.94 6,209 44.53 0.0037
2021-05-13 2021-03-31 13F MYRIAD GENETICS COM 62855J104 141,057 93,915 199.22 4,296 360.94 0.0028
2021-02-11 2020-12-31 13F MYRIAD GENETICS COM 62855J104 47,142 16,976 56.28 932 137.15 0.0006
2020-11-12 2020-09-30 13F MYRIAD GENETICS COM 62855J104 30,166 -120,551 -79.99 393 -77.00 0.0003
2020-08-12 2020-06-30 13F MYRIAD GENETICS COM 62855J104 150,717 23,206 18.20 1,709 -6.36 0.0013
2020-05-12 2020-03-31 13F MYRIAD GENETICS COM 62855J104 127,511 71,221 126.53 1,825 19.05 0.0016
2020-02-12 2019-12-31 13F MYRIAD GENETICS COM 62855J104 56,290 -73,228 -56.54 1,533 -58.66 0.0011
2019-11-08 2019-09-30 13F MYRIAD GENETICS COM 62855J104 129,518 49,545 61.95 3,708 66.95 0.0029
2019-08-12 2019-06-30 13F MYRIAD GENETICS COM 62855J104 79,973 -2,381 -2.89 2,221 -18.76 0.0018
2019-05-13 2019-03-31 13F MYRIAD GENETICS COM 62855J104 82,354 -143,995 -63.62 2,734 -58.45 0.0026
2019-02-12 2018-12-31 13F MYRIAD GENETICS COM 62855J104 226,349 211,259 1,399.99 6,580 848.13 0.0067
2018-11-13 2018-09-30 13F MYRIAD GENETICS COM 62855J104 15,090 8,170 118.06 694 168.99 0.0006
2018-08-10 2018-06-30 13F MYRIAD GENETICS COM 62855J104 6,920 504 7.86 258 36.51 0.0002
2018-05-11 2018-03-31 13F MYRIAD GENETICS COM 62855J104 6,416 -112,463 -94.60 189 -95.37 0.0002
2018-02-12 2017-12-31 13F MYRIAD GENETICS COM 62855J104 118,879 19,748 19.92 4,083 13.86 0.0033
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM 62855J104 99,131 -63,187 -38.93 3,586 -14.52 0.0029
2017-08-11 2017-06-30 13F MYRIAD GENETICS COM 62855J104 162,318 27,107 20.05 4,195 61.59 0.0038
2017-05-12 2017-03-31 13F MYRIAD GENETICS COM 62855J104 135,211 -250,341 -64.93 2,596 -59.61 0.0023
2017-02-10 2016-12-31 13F MYRIAD GENETICS COM 62855J104 385,552 363,402 1,640.64 6,427 1,309.43 0.0058
2016-11-10 2016-09-30 13F MYRIAD GENETICS COM 62855J104 22,150 5,645 34.20 456 -9.70 0.0004
2016-08-12 2016-06-30 13F MYRIAD GENETICS COM 62855J104 16,505 -49,200 -74.88 505 -79.45 0.0005
2016-05-13 2016-03-31 13F MYRIAD GENETICS COM 62855J104 65,705 51,640 367.15 2,458 304.94 0.0028
2016-02-12 2015-12-31 13F MYRIAD GENETICS COM 62855J104 14,065 -12,965 -47.97 607 -40.08 0.0006
2015-11-13 2015-09-30 13F MYRIAD GENETICS COM 62855J104 27,030 7,505 38.44 1,013 52.56 0.0009
2015-08-13 2015-06-30 13F MYRIAD GENETICS COM 62855J104 19,525 3,060 18.58 664 13.89 0.0006
2015-05-14 2015-03-31 13F MYRIAD GENETICS COM 62855J104 16,465 -13,800 -45.60 583 -43.34 0.0006
2015-02-17 2014-12-31 13F MYRIAD GENETICS COM 62855J104 30,265 15,609 106.50 1,029 82.12 0.0009
2014-11-14 2014-09-30 13F MYRIAD GENETICS COM 62855J104 14,656 5,611 62.03 565 60.51 0.0005
2014-08-14 2014-06-30 13F MYRIAD GENETICS COM 62855J104 9,045 -322 -3.44 352 10.00 0.0003
2014-05-15 2014-03-31 13F MYRIAD GENETICS COM 62855J104 9,367 1,435 18.09 320 91.62 0.0003
2014-02-14 2013-12-31 13F MYRIAD GENETICS COM 62855J104 7,932 -10,050 -55.89 167 -60.43 0.0002
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 17,982 16,061 836.07 422 711.54 0.0004
2013-08-14 2013-06-30 13F MYRIAD GENETICS COM 62855J104 1,921 1,921 52 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F MYRIAD GENETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F MYRIAD GENETICS COM Call 15,700 -42.70 310 -13.17 n/a n/a n/a
2020-11-12 2020-09-30 13F MYRIAD GENETICS COM Call 27,400 36.32 357 56.58 n/a n/a n/a
2020-08-12 2020-06-30 13F MYRIAD GENETICS COM Call 20,100 -5.63 228 -25.25 n/a n/a n/a
2020-05-12 2020-03-31 13F MYRIAD GENETICS COM Call 21,300 -13.77 305 -54.68 n/a n/a n/a
2020-02-12 2019-12-31 13F MYRIAD GENETICS COM Call 24,700 -34.31 673 -37.45 n/a n/a n/a
2019-11-08 2019-09-30 13F MYRIAD GENETICS COM Call 37,600 559.65 1,076 581.01 n/a n/a n/a
2019-08-12 2019-06-30 13F MYRIAD GENETICS COM Call 5,700 -37.36 158 -47.68 n/a n/a n/a
2019-05-13 2019-03-31 13F MYRIAD GENETICS COM Call 9,100 279.17 302 331.43 n/a n/a n/a
2019-02-12 2018-12-31 13F MYRIAD GENETICS COM Call 2,400 -63.08 70 -76.59 n/a n/a n/a
2018-11-13 2018-09-30 13F MYRIAD GENETICS COM Call 6,500 -35.64 299 -20.69 n/a n/a n/a
2018-08-10 2018-06-30 13F MYRIAD GENETICS COM Call 10,100 206.06 377 284.69 n/a n/a n/a
2018-05-11 2018-03-31 13F MYRIAD GENETICS COM Call 3,300 312.50 98 262.96 n/a n/a n/a
2018-02-12 2017-12-31 13F MYRIAD GENETICS COM Call 800 -84.31 27 -85.41 n/a n/a n/a
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM Call 5,100 -71.98 185 -60.64 n/a n/a n/a
2017-08-11 2017-06-30 13F MYRIAD GENETICS COM Call 18,200 65.45 470 122.75 n/a n/a n/a
2017-05-12 2017-03-31 13F MYRIAD GENETICS COM Call 11,000 168.29 211 210.29 n/a n/a n/a
2017-02-10 2016-12-31 13F MYRIAD GENETICS COM Call 4,100 95.24 68 58.14 n/a n/a n/a
2016-11-10 2016-09-30 13F MYRIAD GENETICS COM Call 2,100 200.00 43 104.76 n/a n/a n/a
2016-08-12 2016-06-30 13F MYRIAD GENETICS COM Call 700 75.00 21 40.00 n/a n/a n/a
2016-05-13 2016-03-31 13F MYRIAD GENETICS COM Call 400 -77.78 15 -80.77 n/a n/a n/a
2016-02-12 2015-12-31 13F MYRIAD GENETICS COM Call 1,800 38.46 78 59.18 n/a n/a n/a
2015-11-13 2015-09-30 13F MYRIAD GENETICS COM Call 1,300 1,200.00 49 1,533.33 n/a n/a n/a
2015-08-13 2015-06-30 13F MYRIAD GENETICS COM Call 100 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F MYRIAD GENETICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F MYRIAD GENETICS COM Put 47,200 3.06 933 56.28 n/a n/a n/a
2020-11-12 2020-09-30 13F MYRIAD GENETICS COM Put 45,800 -43.87 597 -35.46 n/a n/a n/a
2020-08-12 2020-06-30 13F MYRIAD GENETICS COM Put 81,600 -24.79 925 -40.44 n/a n/a n/a
2020-05-12 2020-03-31 13F MYRIAD GENETICS COM Put 108,500 18.84 1,553 -37.53 n/a n/a n/a
2020-02-12 2019-12-31 13F MYRIAD GENETICS COM Put 91,300 1,117.33 2,486 1,056.28 n/a n/a n/a
2019-11-08 2019-09-30 13F MYRIAD GENETICS COM Put 7,500 -32.43 215 -30.19 n/a n/a n/a
2019-08-12 2019-06-30 13F MYRIAD GENETICS COM Put 11,100 164.29 308 120.00 n/a n/a n/a
2019-05-13 2019-03-31 13F MYRIAD GENETICS COM Put 4,200 223.08 140 268.42 n/a n/a n/a
2019-02-12 2018-12-31 13F MYRIAD GENETICS COM Put 1,300 -66.67 38 -78.77 n/a n/a n/a
2018-11-13 2018-09-30 13F MYRIAD GENETICS COM Put 3,900 200.00 179 265.31 n/a n/a n/a
2018-08-10 2018-06-30 13F MYRIAD GENETICS COM Put 1,300 49 n/a n/a n/a
2018-05-11 2018-03-31 13F MYRIAD GENETICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-12 2017-12-31 13F MYRIAD GENETICS COM Put 1,300 -97.45 45 -97.56 n/a n/a n/a
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM Put 50,900 762.71 1,841 1,111.18 n/a n/a n/a
2017-08-11 2017-06-30 13F MYRIAD GENETICS COM Put 5,900 -21.33 152 5.56 n/a n/a n/a
2017-05-12 2017-03-31 13F MYRIAD GENETICS COM Put 7,500 167.86 144 206.38 n/a n/a n/a
2017-02-10 2016-12-31 13F MYRIAD GENETICS COM Put 2,800 -9.68 47 -26.56 n/a n/a n/a
2016-11-10 2016-09-30 13F MYRIAD GENETICS COM Put 3,100 520.00 64 326.67 n/a n/a n/a
2016-08-12 2016-06-30 13F MYRIAD GENETICS COM Put 500 15 n/a n/a n/a
2016-05-13 2016-03-31 13F MYRIAD GENETICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F MYRIAD GENETICS COM Put 200 -86.67 9 -83.93 n/a n/a n/a
2015-11-13 2015-09-30 13F MYRIAD GENETICS COM Put 1,500 1,400.00 56 1,766.67 n/a n/a n/a
2015-08-13 2015-06-30 13F MYRIAD GENETICS COM Put 100 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.